4//SEC Filing
Mehalick David 4
Accession 0001683168-21-005808
CIK 0001819663other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 2:00 PM ET
Size
4.6 KB
Accession
0001683168-21-005808
Insider Transaction Report
Form 4
Mehalick David
DirectorCEO and President10% Owner
Transactions
- Sale
Common Stock
2021-11-16−1,200,000→ 1,800,000 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected by the reporting person in connection with a divorce settlement.
Documents
Issuer
Coeptis Therapeutics Inc.
CIK 0001819663
Entity typeother
Related Parties
1- filerCIK 0001846623
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 2:00 PM ET
- Size
- 4.6 KB